Department-store chain Sears Holdings is seeking to stem itsbleedingby closing another 150 stores, including 108 Kmart locations, and selling its Craftsman brand to raise cash.
The ailing retailer said Thursday that it had reached a deal to sell the tools brand to Stanley Black & Decker for a net present value of about $900 million, including future royalty payments.
The move came several months after Sears put the Craftsman, Kenmore and DieHard brands up for sale as it seeks an elusive turnaround.
The company said late Wednesdaythat it would close 108 Kmart stores and 42 Sears stores, calling it “adifficult but necessary step as we take actions to strengthen the companys operations and fund its transformation.”
.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } .oembed-link-thumbnail{ float: left; padding: 14px; } .oembed-link-thumbnail img { max-width: 78px; max-height: 60px; display: block; } p.oembed-link-title { font-size: 75%; color: #009BFF; margin: 0 14px; padding-top: 12px; font-weight:normal; text-align: left; line-height: 120%; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }
USA TODAY
Best Heal Care Stocks For 2018: Ono Pharmaceutical Co., Ltd. (OPHLF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.
Best Heal Care Stocks For 2018: Autohome Inc.(ATHM)
Advisors’ Opinion:
- [By R. Chandrasekaran]
The following stocks are rated with Neutral:
JD.Com Inc(ADR) (NASDAQ: JD). Vipshop Holdings Ltd – ADR (NYSE: VIPS). Autohome Inc (ADR) (NYSE: ATHM). SouFun Holdings Ltd (NYSE: SFUN). Leju Holdings Ltd (ADR) (NYSE: LEJU).
Underweight NamesThe following stocks are rated Underweight:
- [By Monica Gerson]
Autohome Inc (ADR) (NYSE: ATHM) is estimated to report its quarterly earnings at $1.68 per share on revenue of $1.05 billion.
Vera Bradley, Inc. (NASDAQ: VRA) is expected to report its quarterly earnings at $0.05 per share on revenue of $106.75 million.
Best Heal Care Stocks For 2018: CIRCOR International, Inc.(CIR)
Advisors’ Opinion:
- [By Lisa Levin]
CIRCOR International, Inc. (NYSE: CIR) was down, falling around 15 percent to $60.91. CIRCOR reported Q4 adjusted earnings of $0.48 per share on revenue of $158 million. Stifel Nicolaus downgraded Circor from Buy to Hold.
